A year has 8,760 hours. Support the campaign
Vitruvian Shield
Oncology

Oncology clinical trials

Structured PRO capture with EORTC QLQ-C30 and PRO-CTCAE, continuous AE monitoring, and remote symptom tracking for decentralised oncology trials.

Modernising oncology trial execution

Oncology trials are among the most complex in clinical research. Multi-arm designs, combination therapies, biomarker-driven stratification, and intensive safety monitoring demand technology that can keep pace. Vitruvian Shield provides oncology-specific workflows purpose-built for the unique challenges of cancer research.

From structured patient-reported outcome capture to continuous adverse event monitoring through wearable biosensors, every module is configured for the velocity and complexity of modern oncology programmes in decentralised and hybrid settings.

Oncology-specific capabilities

Patient-reported outcomes

Structured PRO capture with validated instruments including EORTC QLQ-C30 and PRO-CTCAE, delivered via mobile app with longitudinal quality-of-life tracking for clinical, regulatory, and health economics endpoints.

Treatment response monitoring

Continuous wearable monitoring captures treatment response signals between visits, fatigue patterns, activity decline, vital sign changes, providing early indicators of efficacy or progression.

Symptom burden tracking

Validated oncology PRO instruments (EORTC QLQ-C30, FACT-G, PRO-CTCAE) delivered via mobile app. Track chemotherapy side effects, quality of life and functional status in real time.

Safety signal detection (in development)

In development: AI-assisted monitoring that flags potential adverse events from lab trends, vital signs and patient-reported symptoms, including early signs of hepatotoxicity, cardiotoxicity and immune-related events, for investigator review.

Biomarker-driven stratification

Supports protocols that use biomarker data in randomisation and stratification, such as companion-diagnostic, ctDNA-tracking and adaptive-enrichment designs.

Multi-arm trial support

Supports protocols such as basket, umbrella and adaptive designs, with configurable arms, shared control groups and visit schedules.

Study in preparation

Oncology electronic survey study, ULS Coimbra.

Oncology electronic survey study, ULS Coimbra

In preparation

An observational oncology eSurvey study with clinical investigators at ULS Coimbra, prepared through the TEF-Health facility operated by Instituto Pedro Nunes, using EORTC QLQ-C30 and PRO-CTCAE on the Vitruvian Shield platform. Hosting and ethics arrangements are in preparation.

Instruments and devices
EORTC QLQ-C30 and PRO-CTCAE
Clinical setting
ULS Coimbra, prepared through the TEF-Health facility operated by Instituto Pedro Nunes.
Timeline
Hosting and ethics arrangements are in preparation.

Study parameters are published at the level authorised by the institution. No study result is claimed.

A patient story

HIC01 — Loss of Donors

The human stakes behind clinical-trial data integrity and decentralised recruitment.

Talk to us about your next study

Tell us about the protocol, the countries and the devices. We will show you how the platform would run it.